Cindy Hunter
Medical · Shreveport, LANPI 1669960886
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,124, 3.7 times the $568 reported in 2023.
Across 215 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$783
- Neurocrine Biosciences, Inc.$660
- Teva Pharmaceuticals USA, Inc.$517
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$309
- Axsome Therapeutics, Inc.$306
- E.r. Squibb & Sons, L.L.C.$300
- plus $2K from 12 others
What the payments were for
- Food & beverage$4,515100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 45 | $783 |
| Neurocrine Biosciences, Inc. | 38 | $660 |
| Teva Pharmaceuticals USA, Inc. | 18 | $517 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $309 |
| Axsome Therapeutics, Inc. | 6 | $306 |
| E.r. Squibb & Sons, L.L.C. | 13 | $300 |
| Corium, LLC | 13 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $245 |
| Johnson & Johnson | 10 | $200 |
| AbbVie | 5 | $187 |
| Lundbeck LLC | 9 | $184 |
| Otsuka America Pharmaceutical, Inc. | 8 | $154 |
| Collegium Pharmaceutical, Inc. | 8 | $153 |
| Vanda Pharmaceuticals Inc. | 7 | $136 |
| Tris Pharma Inc | 3 | $53 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Sage Therapeutics, LLC | 1 | $19 |
| Indivior Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,528 in reported general payments places this provider in the 85th percentile of 253 medical providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 22 | $1,743 |
| Hydroxyzine Hcl | 20 | $296 |
| Trazodone Hcl | 21 | $264 |
| Buspirone Hcl | 14 | $235 |
| Mirtazapine | 11 | $139 |
| Risperidone | 21 | $128 |
| Duloxetine Hcl | 12 | $128 |
| Amitriptyline Hcl | 15 | $111 |
| Quetiapine Fumarate | 18 | $60 |
| Clonazepam | 19 | $46 |
| Alprazolam | 14 | $20 |
Paid to pharmacies, not to this prescriber.
Other medical in Shreveport
- Mary McFerrenShreveport$16K
- Seth HendrixShreveport$12K
- Jennifer CypherShreveport$5K
- Brian FontenotShreveport$4K
- Claire HerkeShreveport$4K
- Robert SalterShreveport$3K
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Rachel RhinehartJefferson$16K
- Sydney FussellCovington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.